These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography. Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S Nucl Med Commun; 2003 Jul; 24(7):755-62. PubMed ID: 12813193 [TBL] [Abstract][Full Text] [Related]
24. Tc-99m-MIBI scintigraphy for detecting parathyroid adenoma and hyperplasia. Arbab AS; Koizumi K; Hemmi A; Toyama K; Arai T; Yoshitomi T; Araki T Ann Nucl Med; 1997 Feb; 11(1):45-9. PubMed ID: 9095323 [TBL] [Abstract][Full Text] [Related]
25. [Study of primary hyperparathyroidism by double-phase gammagraphy using Tc99m-MIBI: preoperative detection of pathological glands]. Blanco I; Carril J; Banzo I; Quirce R; Gutiérrez C; Uriarte I; Montero de la Peña A; Hernández A Rev Esp Med Nucl; 1998; 17(1):8-14. PubMed ID: 9609838 [TBL] [Abstract][Full Text] [Related]
26. [Value of 99mTc-MIBI scintigraphy in diagnostic localization of hyperparathyroidism. A prospective study]. Schoenemann B; Wurm K; Bihl H; Merkle P Chirurg; 1996 Jan; 67(1):32-6. PubMed ID: 8851673 [TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging (MRI) and technetium-99m-methoxyisonitrile (MIBI) scintigraphy to evaluate the abnormal parathyroid gland and PEIT efficacy for secondary hyperparathyroidism. Wada A; Sugihara M; Sugimura K; Kuroda H Radiat Med; 1999; 17(4):275-82. PubMed ID: 10510900 [TBL] [Abstract][Full Text] [Related]
28. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism. Billy HT; Rimkus DR; Hartzman S; Latimer RG Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462 [TBL] [Abstract][Full Text] [Related]
29. [Diagnostic imaging in the detection of parotid adenoma. Review of the literature and personal experience with the combined use of computerized tomography and MRI]. Gualdi GF; Ferriano MG; Casciani E; Pirolli C; Polettini E Clin Ter; 1997; 148(5-6):209-24. PubMed ID: 9377856 [TBL] [Abstract][Full Text] [Related]
30. Technetium-99m MIBI uptake in recurrent parathyroid carcinoma and brown tumors. Lu G; Shih WJ; Xiu JY J Nucl Med; 1995 May; 36(5):811-3. PubMed ID: 7738654 [TBL] [Abstract][Full Text] [Related]
31. Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism. Martínez-Rodríguez I; Martínez-Amador N; de Arcocha-Torres M; Quirce R; Ortega-Nava F; Ibáñez-Bravo S; Lavado-Pérez C; Bravo-Ferrer Z; Carril JM Rev Esp Med Nucl Imagen Mol; 2014; 33(2):93-8. PubMed ID: 24125595 [TBL] [Abstract][Full Text] [Related]
32. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi. Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124 [TBL] [Abstract][Full Text] [Related]
33. Tc-99m sestamibi imaging of brown tumors of primary hyperparathyroidism. Dinauer PA; Balingit AG; Rivera JE Clin Nucl Med; 1996 Mar; 21(3):192-6. PubMed ID: 8846562 [TBL] [Abstract][Full Text] [Related]